SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Dr Reddy’s Launches Two New Semaglutide Brands Amid Obeda Supply Disruptions

Dr Reddy’s Laboratories added two generic semaglutide brands as supply disruptions affect its Obeda injections, according to product photographs and marketing materials reviewed by Reuters.

DRREDDY

Related stories